Constance M. Yuan
National Institutes of Health(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Multiple Myeloma Research and Treatments, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial(2014)2,912 cited
- → CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy(2017)1,320 cited
- → The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia(2010)813 cited
- → T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma(2018)782 cited
- → Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia(2012)580 cited
- → Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels(2017)555 cited
- → CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial(2020)406 cited
- → Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial(2014)365 cited
- → Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL(2021)346 cited
- → Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia(2017)338 cited